Emerging Pathogen Preparedness Program Authorization Act

Bill 118 s 2329, also known as the Emerging Pathogen Preparedness Program Authorization Act, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to authorize funding for the Emerging Pathogen Preparedness Program, which aims to enhance the country's preparedness for emerging infectious diseases and other public health threats.

The bill outlines the specific objectives of the program, which include improving surveillance and detection of emerging pathogens, enhancing laboratory capacity for testing and diagnosis, and strengthening the public health response to outbreaks. It also emphasizes the importance of collaboration between federal, state, and local health agencies, as well as international partners, in order to effectively address these threats.

In terms of funding, the bill specifies the amount of money that will be allocated to the program and how it will be distributed. It also includes provisions for oversight and evaluation of the program to ensure that the funds are being used effectively and that the program is achieving its intended goals. Overall, the Emerging Pathogen Preparedness Program Authorization Act is aimed at improving the country's ability to respond to emerging infectious diseases and other public health threats. By authorizing funding for this program, the bill seeks to enhance the nation's preparedness and response capabilities, ultimately protecting the health and safety of the American people.